Pharmafile Logo

Chiltern

Established in 1982 and with experience in over 40 countries, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they do in clinical studies more human – more accessible, insightful,…

View Profile

Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

IPG Health Medical Communications

We are the world’s most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity and technology to exceptional medical communications solutions for our clients.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Company Details

Chiltern, 171 Bath Road, Slough, Berkshire, SL1 4AA, UK
+44 (0)1753 512 000

 Latest Content from PMHub 

PEGASUS STRENGTHENS ITS PHARMA TEAM WITH TWO STAFF APPOINTMENTS

Pegasus shortlisted for three Communiqué awards and hopes to defend its Communications Consultancy of the Year win from 2014

Health Unlimited is proud sponsor of the two corporate communications categories at this year’s Communiqué Awards.

Over the last five years, Health Unlimited agencies have been shortlisted nearly 40 times, picking up a total of eight Communiqué Awards, which recognise the very best in healthcare communications.

ASCO 2015: What you missed in Chicago

Blue Latitude sent two of our consultants to Chicago to attend ASCO 2015, a key annual meeting for oncology specialists that brings over 30,000 delegates together to talk about innovations...

Meet expert speakers: The right e-detailing content for rich data

We are excited to reveal the names of the expert speakers at Anthill's next webinar "The right e-detailing content for rich data" on the 3rd June 2015, 3 PM GMT+2.

How do you solve a problem like non-adherence? Part 2

Following her previous piece on patient medical non-adherence, Head of Customer Experience Elisa del Galdo takes a look at the different patient personas that emerge during the diagnosis and treatment...

Webinar: The right e-detailing content for rich data

Data is the fuel for your digital communication – powering you to not only learn about your customers but communicate more effectively too.

How do you solve a problem like non-adherence? Part 1

Recent research from the World Health Organisation and the Mayo Clinic on the impact of (and influences on) a patient’s ability to adhere to their treatment regime has shown that...

How to design patient services with social media within the ABPI code guidelines

In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.

Infographic: PsO market snapshot

An overview of the PsO biologic and systemic patientOur PsO market snapshot offers an introduction to the real world patient data collected by our Therapy Watch PsO study. The snapshot...

Infographic: Prostate Cancer Market Snapshot

An overview of the prostate cancer patientDownload our Therapy Watch PCa market snapshot which provides you with an overview of the prostate cancer patient and the therapy regimens followed by...